Neoadjuvant chemotherapy in advanced ovarian cancer: what is the optimal number of cycles?

被引：0
|
作者：
Ltaief, Sarra Ben [1 ]
Bouhani, Malek [1 ]
Houissa, Iness [1 ]
Sakhri, Saida [1 ]
Bouaziz, Hanen [1 ]
Dhiab, Tarek Ben [1 ]
机构：
[1] Inst Salah Aziez Tunisia, Surg Oncol, Tunis Ville, Tunisia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV225
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in advanced ovarian cancer: optimal patient selection and response evaluation
    Cho, Jae Hyun
    Kim, Seik
    Song, Yong Sang
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [22] Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
    D'Andrea, David
    Black, Peter C.
    Zargar, Homayoun
    Dinney, Colin P.
    Soria, Francesco
    Cookson, Michael S.
    Montgomery, Jeffrey S.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Sridhar, Srikala S.
    McGrath, John S.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Holzbeierlein, Jeff M.
    Carrion, Diego M.
    Di Trapani, Ettore
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Grivas, Petros
    Stephenson, Andrew J.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Shariat, Shahrokh F.
    Zargar-Shoshtar, Kamran
    Mertens, Laura S.
    Fairey, Adrian S.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Jacobsen, Niels-Erik
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Pradere, Benjamin
    Pichler, Renate
    Campain, Nicholas J.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Aning, Jonathan
    Morgan, Todd M.
    Shah, Jay B.
    Moschini, Marco
    JOURNAL OF UROLOGY, 2022, 207 (01): : 70 - 76
  • [23] Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
    Vergote, Ignace
    Amant, Frederic
    Leunen, Karin
    du Bois, Andreas
    Heitz, Florian
    Harter, Philipp
    GYNECOLOGIC ONCOLOGY, 2013, 128 (01) : 6 - 11
  • [24] Neoadjuvant chemotherapy for advanced ovarian cancer - Reply
    Schwartz, PE
    Chambers, JT
    Rutherford, TJ
    Thiel, RP
    GYNECOLOGIC ONCOLOGY, 1999, 74 (02) : 312 - 313
  • [25] Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer
    Avendano, Juan
    Buitrago, Giancarlo
    Ramos, Pedro
    Suescun, Oscar
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2010, 14 (01): : 14 - 21
  • [26] Value of neoadjuvant chemotherapy in advanced ovarian cancer
    Federico Coccolini
    Fausto Catena
    Roberto Manfredi
    Giulia Montori
    Jennifer E Manegold
    Luca Ansaloni
    World Journal of Obstetrics and Gynecology, 2015, (03) : 64 - 67
  • [27] Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer
    Hall, Tracilyn R.
    Dizon, Don S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (04) : 262 - 268
  • [28] NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER
    SCHWARTZ, PE
    CHAMBERS, JT
    MAKUCH, R
    GYNECOLOGIC ONCOLOGY, 1994, 53 (01) : 33 - 37
  • [29] Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
    Perrone, Anna Myriam
    Coada, Camelia Alexandra
    Ravegnini, Gloria
    De Leo, Antonio
    Damiano, Giuseppe
    De Crescenzo, Eugenia
    Tesei, Marco
    Di Costanzo, Stella
    Genovesi, Lucia
    Rubino, Daniela
    Zamagni, Claudio
    De Iaco, Pierandrea
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (08) : 1270 - 1278
  • [30] Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
    Liu, Ying L.
    Zhou, Qin C.
    Iasonos, Alexia
    Chi, Dennis S.
    Zivanovic, Oliver
    Sonoda, Yukio
    Gardner, Ginger
    Broach, Vance
    O'Cearbhaill, Roisin
    Konner, Jason A.
    Grisham, Rachel
    Aghajanian, Carol A.
    Abu-Rustum, Nadeem R.
    Tew, William
    Long Roche, Kara
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (12) : 1915 - 1921
12345